NCT07133776 2025-08-21
Application of PD-1 Inhibitors Combined With Tenofovir, Chidamide and Lenalidomide in the Treatment of EBV-associated Diseases.
The Affiliated Hospital of Xuzhou Medical University
Phase 1/2 Not yet recruiting
Clinical Trials
11 trialsNCT03887702 2024-05-20
Prophylactic Antiviral Therapy in Patients With Current or Past Hepatitis B Virus Infection Receiving Anti-Cancer Therapy for Solid Tumors
SWOG Cancer Research Network
Phase 3 Terminated
NCT02650271 2024-01-23
Adjuvant Entecavir or Tenofovir for Postoperative HBV-HCC
Guangxi Medical University
Phase 3 Completed
NCT02224456 2022-02-14
Efficacy and Safety Study of Tenofovir Disoproxil Fumarate (TDF) in Chinese Chronic Hepatitis B (CHB) Subjects With Advanced Fibrosis & Compensated Cirrhosis
GlaxoSmithKline
Phase 4 Completed
NCT04392700 2020-05-19
A RCT of TNF and ENT in the Treatment of Long-term Prognosis With Hepatitis B-related HCC After Curative Resection
Sun Yat-sen University
Phase 3 Unknown
NCT02081469 2020-02-05
Prophylaxis of CHB Patients With Malignant Tumor Receiving Chemotherapy
Chang Gung Memorial Hospital
Phase 4 Completed
NCT02186574 2019-12-12
Tenofovir to Prevent HBV Reactivation
University Health Network, Toronto
Phase 3 Unknown
NCT02585947 2016-12-21
To Compare the Efficacy of a Prophylactic Use of Tenofovir by Duration for the Non-Hodgkin's Lymphoma
Seoul National University Hospital
Phase 4 Unknown
NCT01528865 2016-03-11
Safety & Efficacy of Lamivudine & Tenofovir to Lower Plasma Level of Viral RNA in Lymphoma
University of Michigan Rogel Cancer Center
Phase 1/2 Withdrawn
NCT02308319 2014-12-04
POWER
Samsung Medical Center
Phase 4 Unknown
NCT01872988 2014-09-04
Tenofovir Antiviral Therapy Following Transarterial Chemoembolization for HBV Related Hepatocellular Carcinoma
Taichung Veterans General Hospital
Phase 3 Terminated